Table 1.
Comparison of Those Who Died Within 30 Days vs. Those Who Surviveda
| Survival (n=107) | Mortality (n=12) | p-value | |
|---|---|---|---|
| Age | 59 (45–73) | 70 (49–76) | 0.203 |
| Male Gender | 64 (59.8) | 7 (58.3) | >0.999 |
| Caucasian | 92 (86.0) | 11 (91.7) | >0.999 |
| Prior Hospitalization | 53 (49.5) | 6 (50.0) | >0.999 |
| Comorbid Conditions | |||
| Immunocompromising Condition | 14 (13.1) | 3 (25.0) | 0.376 |
| Diabetes | 49 (45.8) | 5 (41.7) | >0.999 |
| Injection Drug Use | 18 (16.8) | 3 (25.0) | 0.442 |
| Chronic Lung Disease | 18(16.8) | 2 (16.7) | >0.999 |
| Renal Disease | 60 (56.1) | 8 (66.7) | 0.552 |
| Hemodialysis | 13 (12.2) | 1 (8.3) | >0.999 |
| Liver Disease | 16 (15.0) | 3 (25.0) | 0.404 |
| Congestive Heart Failure | 25 (23.4) | 6 (50.0) | 0.076 |
| Charlson Comorbidity Index | 4 (2–7) | 5 (2.5–7.0) | 0.512 |
| Methicillin-sensitive Staphylococcus aureus | 75 (70.1) | 7 (58.3) | 0.512 |
| Time to Blood Culture Positivity, Hours | 18 (15–21) | 14 (12–19) | 0.041 |
| Bacteremia Source | 0.047 | ||
| Endovascular | 11 (10.3) | 4 (33.3) | |
| Catheter or Secondary, Non-Endovascular | 96 (89.7) | 8 (66.7) | |
| PITT Bacteremia Score | 1 (0–2) | 4 (2–4.5) | <0.001 |
| Catheter or Prosthesis | 34 (31.8) | 2 (16.7) | 0.343 |
| Complete Blood Count Variables, Day of First Positive Blood Culture | |||
| White Blood Cell Count | 14.2 (10.6–20.2) | 17.8 (12.2–21.4) | 0.312 |
| Absolute Neutrophil Count | 12 (8.5–17.5) | 16.1 (11.4–19.3) | 0.173 |
| Lymphocyte Count | 0.9 (0.6–1.5) | 0.6 (0.3–0.9) | 0.030 |
| Neutrophil to Lymphocyte Count Ratio | 13.6 (8.4–21.3) | 23.2 (17.1–46.5) | 0.007 |
| Platelet Count | 239 (166–306) | 171 (114–195) | 0.018 |
| Eosinophil Count | 0 (0–0.1) | 0 (0–0) | 0.433 |
| Red Blood Cell Distribution Width | 14.2 (13.2–15.3) | 14.3 (13.3–17.5) | 0.740 |
| Automated Differential | 91 (85.0) | 9 (75.0) | 0.404 |
a
All data presented as No. (%) or median (interquartile range).